Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma
MD Prados, SM Chang, N Butowski… - Journal of Clinical …, 2009 - ascopubs.org
Purpose This open-label, prospective, single-arm, phase II study combined erlotinib with
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
[HTML][HTML] Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
MD Prados, SM Chang, N Butowski… - Journal of Clinical …, 2009 - ncbi.nlm.nih.gov
Purpose This open-label, prospective, single-arm, phase II study combined erlotinib with
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
[引用][C] Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
MD PRADOS, SM CHANG… - Journal of clinical …, 2009 - pascal-francis.inist.fr
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients
With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma CNRS Inist Pascal-Francis …
With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma CNRS Inist Pascal-Francis …
[PDF][PDF] Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
MD Prados, SM Chang, N Butowski, R DeBoer… - J Clin Oncol, 2008 - academia.edu
Purpose This open-label, prospective, single-arm, phase II study combined erlotinib with
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
[PDF][PDF] Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
MD Prados, SM Chang, N Butowski, R DeBoer… - J Clin …, 2008 - researchgate.net
Purpose This open-label, prospective, single-arm, phase II study combined erlotinib with
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.
MD Prados, SM Chang, N Butowski… - Journal of Clinical …, 2008 - europepmc.org
Purpose This open-label, prospective, single-arm, phase II study combined erlotinib with
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
[引用][C] Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
MD Prados, SM Chang… - Journal of …, 2009 - baptisthealth.elsevierpure.com
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients
With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma — Baptist Health South …
With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma — Baptist Health South …
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma
MD Prados, SM Chang, N Butowski… - Journal of clinical …, 2009 - pubmed.ncbi.nlm.nih.gov
Purpose This open-label, prospective, single-arm, phase II study combined erlotinib with
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma
MD Prados, SM Chang, N Butowski… - Journal of Clinical …, 2009 - scholars.northwestern.edu
Purpose: This open-label, prospective, single-arm, phase II study combined erlotinib with
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
MD Prados, SM Chang, N Butowski, R DeBoer… - Journal of Clinical …, 2009 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> This open-label, prospective,
single-arm, phase II study combined erlotinib with radiation therapy (XRT) and …
single-arm, phase II study combined erlotinib with radiation therapy (XRT) and …